Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.09 USD
Change Today -0.94 / -2.24%
Volume 171.2K
ENTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:28 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert C. Moellering Jr., M.D.

AgeTotal Calculated CompensationThis person is connected to 77 board members in 9 different organizations across 15 different industries.

See Board Relationships
----

Background*

Dr. Robert C. Moellering, Jr., M.D. is a Clinical Advisor of Enanta Pharmaceuticals, Inc. Dr. Moellering serves as an Editor-in-Chief of Antimicrobial Agents and Chemotherapy and serves as Editor of both Infectious Disease Clinics of North America and European Journal of Clinical Microbiology and Infectious Diseases. He was the President and Chief Executive Officer of Harvard Medical Faculty Physicians of Beth Israel Deaconess Medical Center, the faculty multispecialty ...

Read Full Background

Corporate Headquarters*

500 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-607-0800
Fax: 617-607-0530

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
Harvard Medical School
Honorary Doctorate
Valparaiso University
BA
Valparaiso University
Master's Degree
American College of Physicians

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENTA:US $41.09 USD -0.94

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENANTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.